Previous reports demonstrated the clinical benefits of antibiotic and TNF-α inhibitor combination therapies relating to both arthritis severity and bone destruction in addition to reductions in the mortality rate by a combination therapy in experimental S. aureus–induced septic arthritis [55]. Here, TNF is linked to bacterial arthritis.